30-Day FRN

lotter on DSK11XQN23PROD with NOTICES1

Federal Register / Vol. 90, No. 222 / Thursday, November 20, 2025 / Notices
Gulfstream LNG Development, LLC
(Gulfstream LNG). Gulfstream LNG is
seeking relief from compliance with
certain requirements in the Federal
pipeline safety regulations. PHMSA has
proposed conditions to ensure the
special permit is consistent with
pipeline safety. At the conclusion of the
30-day comment period, PHMSA will
review the comments received from this
notice as part of its evaluation to grant
or deny the special permit request.
DATES: Submit any comments regarding
this special permit request by December
22, 2025.
ADDRESSES: Comments should reference
the docket number for this special
permit request and may be submitted in
the following ways:
• E-Gov Website: http://
www.regulations.gov. This site allows
the public to enter comments on any
Federal Register Notice issued by any
agency.
• Fax: 1–202–493–2251.
• Mail: Docket Management System:
U.S. Department of Transportation,
Docket Operations, M–30, West
Building Ground Floor, Room W12–140,
1200 New Jersey Avenue SE,
Washington, DC 20590.
• Hand Delivery: Docket Management
System: U.S. Department of
Transportation, Docket Operations, M–
30, West Building Ground Floor, Room
W12–140, 1200 New Jersey Avenue SE,
Washington, DC 20590, between 9:00
a.m. and 5:00 p.m., Monday through
Friday, except Federal holidays.
Instructions: You should identify the
docket number for the special permit
request you are commenting on at the
beginning of your comments. If you
submit your comments by mail, please
submit two copies. To receive
confirmation that PHMSA has received
your comments, please include a selfaddressed stamped postcard. Internet
users may submit comments at http://
www.regulations.gov.
Note: There is a privacy statement
published on http://
www.regulations.gov. Comments,
including any personal information
provided, are posted without changes or
edits to http://www.regulations.gov.
Confidential Business Information:
Confidential Business Information (CBI)
is commercial or financial information
that is both customarily and actually
treated as private by its owner. Under
the Freedom of Information Act (FOIA)
(5 United States Code § 552), CBI is
exempt from public disclosure. If your
comments responsive to this notice
contain commercial or financial
information that is customarily treated
as private, that you treat as private, and

VerDate Sep<11>2014

19:07 Nov 19, 2025

Jkt 268001

that is relevant or responsive to this
notice, it is important that you clearly
designate the submitted comments as
CBI. Pursuant to 49 Code of Federal
Regulation (CFR) § 190.343, you may
ask PHMSA to give confidential
treatment to information you give to the
Agency by taking the following steps:
(1) mark each page of the original
document submission containing CBI as
‘‘Confidential’’; (2) send PHMSA, along
with the original document, a second
copy of the original document with the
CBI deleted; and (3) explain why the
information you are submitting is CBI.
Unless you are notified otherwise,
PHMSA will treat such marked
submissions as confidential under the
FOIA, and they will not be placed in the
public docket of this notice.
Submissions containing CBI should be
sent to Lee Cooper, DOT, PHMSA–PHP–
80, 1200 New Jersey Avenue SE,
Washington, DC 20590–0001. Any
commentary PHMSA receives that is not
specifically designated as CBI will be
placed in the public docket for this
matter.
FOR FURTHER INFORMATION CONTACT:
General: Mr. Lee Cooper by phone at
202–913–3171 or by email at
[email protected].
Technical: Ms. Chau Tran by phone at
713–249–2483 or by email at chau.tran@
dot.gov.
SUPPLEMENTARY INFORMATION: PHMSA
received a special permit request from
Gulfstream LNG on September 17, 2025,
seeking to waive certain requirements in
the Federal pipeline safety regulations
that would apply otherwise to the
design, construction, and testing of a
proposed LNG storage tank in
Plaquemines Parish, Louisiana.
Gulfstream LNG is proposing to
construct and operate gas treatment,
liquefaction, LNG storage, truck loading,
and marine facilities (collectively
known as the Gulfstream LNG Project or
the Project) for the purpose of liquefying
domestic natural gas for export to
foreign markets as LNG. The proposed
project would include a membrane tank,
to be used for LNG storage, with a
nominal working volume of 200,000
cubic meters or 1,258,000 barrels.
Gulfstream LNG seeks to waive the
requirements of 49 CFR 193.2101(a),
193.2301, and 193.2303, which
incorporate by reference the 2001
edition of National Fire Protection
Association (NFPA) 59A–2001,
‘‘Standard for the Production, Storage,
and Handling of Liquefied Natural Gas
(LNG),’’ for the design, construction,
and testing of LNG facilities, including
the design of LNG storage tanks.
Specifically, Gulfstream LNG is

PO 00000

Frm 00141

Fmt 4703

Sfmt 4703

52493

applying for a special permit to
authorize the design and construction of
a membrane containment tank system
(membrane tank) in accordance with the
2023 edition of NFPA–59A, which is
not incorporated by reference in 49 CFR
part 193.
The special permit request and the
proposed special permit conditions for
Gulfstream LNG’s request are available
for review and public comment in
Docket No. PHMSA–2025–1073.
PHMSA invites interested persons to
review and submit comments in the
docket on the special permit request and
the proposed special permit conditions.
Please submit comments on any
potential safety, environmental, and
other relevant considerations implicated
by the special permit request.
Comments may include relevant data.
Before issuing a decision on the
special permit request, PHMSA will
evaluate all comments received on or
before the closing date. PHMSA will
consider each relevant comment it
receives in making its decision to grant
or deny this special permit request.
Issued in Washington, DC, on November
17,2025, under authority delegated in 49 CFR
1.97.
Linda Daugherty,
Acting Associate Administrator for Pipeline
Safety.
[FR Doc. 2025–20337 Filed 11–19–25; 8:45 am]
BILLING CODE 4910–60–P

DEPARTMENT OF VETERANS
AFFAIRS
[OMB Control No. 2900–0463]

Agency Information Collection Activity
Under OMB Review: Notice of Waiver
of VA Compensation or Pension To
Receive Military Pay and Allowances
Veterans Benefits
Administration, Department of Veterans
Affairs.
ACTION: Notice.
AGENCY:

In compliance with the
Paperwork Reduction Act (PRA) of
1995, this notice announces that the
Veterans Benefits Administration
(VBA), Department of Veterans Affairs,
will submit the collection of
information abstracted below to the
Office of Management and Budget
(OMB) for review and comment. The
PRA submission describes the nature of
the information collection and its
expected cost and burden, and it
includes the actual data collection
instrument.
DATES: Comments and
recommendations for the proposed
SUMMARY:

E:\FR\FM\20NON1.SGM

20NON1

52494

Federal Register / Vol. 90, No. 222 / Thursday, November 20, 2025 / Notices

information collection should be sent by
December 22, 2025.

DEPARTMENT OF VETERANS
AFFAIRS

To submit comments and
recommendations for the proposed
information collection, please type the
following link into your browser:
www.reginfo.gov/public/do/PRAMain,
select ‘‘Currently under Review—Open
for Public Comments’’, then search the
list for the information collection by
Title or ‘‘OMB Control No. 2900–0463.’’

[Docket No. VA–2025–VACO–0001]

ADDRESSES:

FOR FURTHER INFORMATION CONTACT:

VA

PRA information: Dorothy Glasgow,
202–461–1084, [email protected].

lotter on DSK11XQN23PROD with NOTICES1

SUPPLEMENTARY INFORMATION:

Title: Notice of Waiver of VA
Compensation or Pension to Receive
Military Pay and Allowances (VA Form
21–8951–2).
OMB Control Number: 2900–0463.
https://www.reginfo.gov/public/do/
PRASearch.
Type of Review: Revision of a
currently approved collection.
Abstract: VA Form 21–8951–2 is used
by reservists/guardsmen filing a waiver
of VA disability benefits to receive
active or inactive duty training pay or to
notify VA to resume benefits as his/her
active service has completed. Without
this information, the reduction in
overpayments and/or erroneous
payments associated with receipt of VA
disability compensation or pension
could cause hardship on behalf of the
claimant.
An agency may not conduct or
sponsor, and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number. The Federal Register
Notice with a 60-day comment period
soliciting comments on this collection
of information was published at [insert
citation date]: 90 FR 44478, September
15, 2025.
Affected Public: Individuals or
Households.
Estimated Annual Burden: 5,766
hours.
Estimated Average Burden per
Respondent: 10 minutes.
Frequency of Response: One time.
Estimated Number of Respondents:
34,594 per year.
Authority: 44 U.S.C. 3501 et seq.
Shunda Willis,
Acting, VA PRA Clearance Officer, (Alt.)
Office of Information Technology,
Department of Veterans Affairs.
[FR Doc. 2025–20351 Filed 11–19–25; 8:45 am]
BILLING CODE 8320–01–P

VerDate Sep<11>2014

19:07 Nov 19, 2025

Jkt 268001

Decision Following the Formal
Evaluation on the Relationship
Between Exposure to Fine Particulate
Matter and Certain Blood Conditions
Department of Veterans Affairs.
Notice.

AGENCY:
ACTION:

The Department of Veterans
Affairs (VA) is issuing notice of the
Secretary’s determination under title 38
United States Code (U.S.C.) 1174(a)(2)
that a presumption of service
connection is not warranted for
polycythemia vera, essential
thrombocythemia, histiocytosis,
mastocytosis, and chronic
myeloproliferative disease for veterans
exposed to fine particulate matter
(PM2.5) while serving in the Southwest
Asia Theater of Operations or Somalia
on or after August 2, 1990, or in
Afghanistan, Egypt, Jordan, Lebanon,
Syria, Yemen, Djibouti, or Uzbekistan
on or after September 11, 2001.
FOR FURTHER INFORMATION CONTACT: Dr.
Erin Dursa, Veterans Health
Administration, 202–461–7297.
SUPPLEMENTARY INFORMATION: 38 U.S.C.
1171–74 details the process for
determining presumptions of service
connection based on toxic exposures.
On November 20, 2024, the Secretary of
Veterans Affairs directed a formal
evaluation 1 of five blood conditions,
including polycythemia vera, essential
thrombocythemia, histiocytosis,
mastocytosis, and chronic
myeloproliferative disease for veterans
exposed to PM2.5 while serving in the
Southwest Asia theater of operations or
Somalia on or after August 2, 1990, or
in Afghanistan, Egypt, Jordan, Lebanon,
Syria, Yemen, Djibouti, or Uzbekistan
on or after September 11, 2001.
VA conducted a formal evaluation
between November 2024 and March
2025 that considered available medical
evidence, Veterans Health
Administration (VHA) health care data,
Veterans Benefits Administration (VBA)
claims data, and other factors, as
required by 38 U.S.C. 1173. A structured
literature search did not yield any
SUMMARY:

1 Report to The Secretary of Veterans Affairs on
the Formal Evaluation on The Relationship
Between Exposure to Fine Particulate Matter (PM2.5)
in the Southwest Theater of Operations or Somalia
on or after August 2, 1990, or in Afghanistan, Egypt,
Jordan, Lebanon, Syria, Yemen, Djibouti, or
Uzbekistan on or after September 11, 2001, and
Polycythemia Vera, Essential Thrombocythemia,
Histiocytosis, Mastocytosis, and Chronic
Myeloproliferative Disease, May 2025 (hereafter
‘‘Formal Evaluation Report’’) is available at
www.regulations.gov.

PO 00000

Frm 00142

Fmt 4703

Sfmt 4703

papers that were directly relevant to
assessing the relationship between
exposure to PM2.5 and polycythemia
vera, essential thrombocythemia,
histiocytosis, mastocytosis, and chronic
myeloproliferative disease.
Additionally, the formal evaluation
analyzed VHA electronic medical record
data for the five conditions of interest
between Calendar Year (CY) 2016 and
CY24. The results indicate that the nineyear prevalence of these conditions
among post-9/11 veterans who served in
the Southwest Asia theater of operations
who use VHA health care was lower
than the prevalence in the general
population. The nine-year prevalence of
these conditions among the 1990–1991
Gulf War Era veteran population
utilizing VHA health care was higher
than the general population, except for
mastocytosis; this was observed in both
veterans who deployed to Southwest
Asia and those who served during the
time period of the war but did not
deploy. This is likely due to this veteran
population’s older age distribution.
The formal evaluation also analyzed
VBA claims data for polycythemia vera,
essential thrombocythemia,
histiocytosis, mastocytosis, and chronic
myeloproliferative disease across four
Gulf War Era cohorts, encompassing a
total of 11,022,410 veterans. Between
2005 and 2025, 3,507 of those veterans
filed claims for these conditions. The
claim filing rate for these blood
conditions varied minimally across
cohorts, ranging from 0.01% to 0.06%.
Among the claims, 1,777 veterans were
granted service connection. The grant
rate across the four cohorts was 50.67%.
The service connection prevalence rate
was low and consistent across cohorts.
The formal evaluation report was
reviewed by hematologists/oncologists
at the National Oncology Program
Office.
Based on the findings from the formal
evaluation, including a literature search
and the analysis of VHA and VBA data,
the Secretary has determined that a
presumption of service connection is
not warranted for polycythemia vera,
essential thrombocythemia,
histiocytosis, mastocytosis, or chronic
myeloproliferative disease for veterans
exposed to fine particulate matter
(PM2.5) while serving in the Southwest
Asia Theater of Operations or Somalia
on or after August 2, 1990, or in
Afghanistan, Egypt, Jordan, Lebanon,
Syria, Yemen, Djibouti, or Uzbekistan
on or after September 11, 2001.
Currently available evidence is not
sufficient to conclude, or is not
sufficient to make a scientifically
informed judgment, that a positive
association as likely as not exists

E:\FR\FM\20NON1.SGM

20NON1